subscribeSubscribe
UK MHRA grants Mkt approval for ViiV`s cabotegravir formulations prevent HIV-1

UK MHRA grants Mkt approval for ViiV`s cabotegravir formulations prevent HIV-1
PHARMABIZ
04 May 2024
Share Share
ViiV Healthcare Announces Data at CROI Indicating Efficacy of Cabenuva

ViiV Healthcare Announces Data at CROI Indicating Efficacy of Cabenuva
BUSINESSWIRE
06 Mar 2024
Share Share
GSK`s new HIV drug formula could support longer dosing intervals

GSK`s new HIV drug formula could support longer dosing intervals
PRESS RELEASE
05 Mar 2024
Share Share
GSK`s injectable HIV drug shows promise over daily pills

GSK`s injectable HIV drug shows promise over daily pills
PRESS RELEASE
22 Feb 2024
Share Share
ViiV Healthcare receives approval from China’s NMPA for Vocabria

ViiV Healthcare receives approval from China’s NMPA for Vocabria
PRESS RELEASE
27 Oct 2023
Share Share
European Commission authorises GSK`s HIV prevention drug

European Commission authorises GSK`s HIV prevention drug
REUTERS
20 Sep 2023
Share Share
MSF calls out GSK`s ViiV for nondisclosure clauses in contract

MSF calls out GSK`s ViiV for nondisclosure clauses in contract
Zoey Becker FIERCE PHARMA
17 Aug 2023
Share Share
GSK`s HIV prevention drug recommended for marketing approval in Europe

GSK`s HIV prevention drug recommended for marketing approval in Europe
PRESS RELEASE
25 Jul 2023
Share Share
GSK`s ViiV explores novel pathway to expand long-acting HIV drug

GSK`s ViiV explores novel pathway to expand long-acting HIV drug
Angus Liu FIERCE PHARMA
06 Jul 2023
Share Share
GSK licenses companies to make cheap copies of HIV prevention drug

GSK licenses companies to make cheap copies of HIV prevention drug
REUTERS
30 Mar 2023
Share Share